Hospital-Acquired Infection Control Market: Current Analysis and Forecast (2021-2027)

Emphasis on Product & Service (Protective Barriers, Sterilization, Disinfectants, Disinfectors, Endoscope Reprocessing Products, and Others); End-user (Hospitals & ICUs, Ambulatory Surgical & Diagnostic Centers, and Others); Region/Country

Geography:

Global

Industry:

Healthcare

Last updated:

May 2022

Hospital-Acquired Infection Control 2
Hospital-Acquired Infection Control 2

The global hospital-acquired infection control (HAIC) Market is anticipated to grow with an elevated CAGR of around 4% over the forecast period (2021-2027). Hospital-Acquired Infections are the infections that occur in hospitals due to contaminated equipment, furniture, washrooms, or others. Diseases like sepsis, tuberculosis, and influenza are commonly spread from hospitals.


REQUEST FREE SAMPLE PDF


With the rapid advancement in sterilization technology and rising awareness about personal and environmental hygiene, many industry players are focusing on expanding their portfolio by launching new services and products in the market. Thus, supporting the HAIC market growth during the forecast period. For example, in August 2021- STERIS announced the addition of Vesta-Syde SQ 64 st Ready-to-Use Disinfectant Wipes to its comprehensive disinfectant product line. Vesta-Syde SQ 64 st Ready-to-Use (RTU) Disinfectant Wipes use an innovative system that combines cleanroom quality wipes packaged with a separate internal pouch containing the quaternary ammonium active ingredient. The internal pouch allows for maximum chemical stability while offering a simple, convenient, and consistent method to saturate the wipes. Furthermore, the demand for HAIC is increasing on account of the growth in the aging population coupled with the rising prevalence of numerous chronic diseases across the globe.


STERIS plc, Sotera Health Company, Getinge AB, Advanced Sterilization Products, Ecolab Inc., 3M Company, MATACHANA GROUP, MMM Group, Belimed AG, Reckitt Benckiser.,  are some of the prominent players operating in the Hospital- Acquired Infection Control (HAIC) market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with new varieties of Hospital- Acquired Infection Control (HAIC) devices.


Insights Presented in the Report


“Amongst Product & Services,  protective barriers segment holds the major share”


Based on products & services, the market is segmented into protective barriers, sterilization, disinfectants, disinfectors, endoscope reprocessing products, and others. The protective barriers segment accounted for a significant market share in 2020 and it is estimated that it will exhibit a higher CAGR during the forecast period. The growth of this segment is mainly due to the increasing number of HAIs globally. According to CDC, there is a significant increase in the HAI events such as central line-associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), ventilator-associated events (VAEs), surgical site infections (SSIs), and methicillin-resistant Staphylococcus aureus (MRSA) bloodstream events between 2019 and 2020. VAEs increased by 35%, CLABSI increased by 24%, and MRSA increased by 15%. Furthermore, the lower product cost and easy availability significantly contribute to the market of HAIs during the forecast period.


REQUEST FOR CUSTOMIZATION


“Amongst End-user, senior citizen segment holds the major share”


Based on end-user, the market is divided into hospitals & ICUs, ambulatory surgical & diagnostic centers, and others. The hospital segment grabbed a significant market share in 2020 and is anticipated to grow at a steady rate in the upcoming years owing to the rapidly increasing geriatric population and rising prevalence of various chronic diseases among them. For instance, as per the WHO, between 2015 and 2050, the proportion of the world’s population over 60 years will nearly double from 12% to 22%. Also, 1 in 6 people in the world will be aged 60 years or over by 2030. Moreover, the increasing investments in better healthcare infrastructure and increasing government and WHO regulations for disease control are likely to positively influence the segment in the HAI control market during the forecast period.


“APAC represents one of the largest markets of Hospital- Acquired Infection Control (HAIC) market”


For a better understanding of the market dynamics of the Hospital- Acquired Infection Control (HAIC) market, a detailed analysis was conducted for different regions across the globe including North America (U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. North America constitutes a major share in the industry. The major factors such as favorable government initiatives, and increased investments in research and development to reduce risk from HAI coupled with the rapid increase in the geriatric population are propelling the growth of this market in the region. For instance, the number of Americans aged 60 and older increased by 34% from 55.7 million to 74.6 million between 2009 and 2019.


SPEAK TO ANALYST


Reasons to buy this report:



  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts

  • The report presents a quick review of overall industry performance at one glance

  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments

  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry

  • The study comprehensively covers the market across different segments

  • Deep dive regional level analysis of the industry


Customization Options:


The global Hospital- Acquired Infection Control (HAIC) market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.


Table of Contents

Research Methodology for the Global Hospital- Acquired Infection Control (HAIC) Market Analysis (2021-2027)


Analyzing the historical market, estimating of the current market, and forecasting the future market of the global HAIC market were the three major steps undertaken to create and analyze the adoption of hospital-acquired infection control in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global HAIC market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:


Seek More Details About Research Methodology


Analysis of Historical Market Size


Step 1: In-Depth Study of Secondary Sources:


Detail secondary study was conducted to obtain the historical market size of the Hospital- Acquired Infection Control through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.


Step 2: Market Segmentation:


After obtaining the historical market size of the HAIC market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as product & services and end-users. Further country-level analyses were conducted to evaluate the overall adoption of HAIC measures across the globe.


Step 3: Factor Analysis:


After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the HAIC. Further, we conducted factor analysis using dependent and independent variables such as the growing number of people with chronic diseases and the increasing elderly population all over the globe. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the Hospital-Acquired Infection Control (HAIC) sector across the globe.


Current Market Size Estimate & Forecast


Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the Hospital-Acquired Infection Control (HAIC) market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.


Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., top-down/bottom-up approach was applied to arrive at the market forecast about 2027 for different segments and subsegments across the major markets globally. The research methodology adopted to estimate the market size encompasses:



  • The industry’s market size, in terms of value (US$) and the adoption rate of Hospital- Acquired Infection Control (HAIC) across the major markets domestically

  • All percentage shares, splits, and breakdowns of market segments and sub-segments

  • Key players in the Hospital-Acquired Infection Control (HAIC) market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market


Market Size and Share Validation


Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.


Seek More Details About Research Methodology


Split of Primary Participants in Different Regions


Hospital-Acquired Infection Control 1
Hospital-Acquired Infection Control 1

Market Engineering


Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the HAIC market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of product & services and end-users of the HAIC market.


The main objective of the Hospital-Acquired Infection Control (HAIC) Market Study


The current & future market trends of HAIC were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:



  • Analyze the current and forecast market size of HAIC in terms of value (US$). Also, analyze the current and forecast market size of different segments and sub-segments

  • Segments in the study include areas of product type and application

  • Define and analysis of the regulatory framework for the HAIC industry

  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry

  • Analyze the current and forecast market size of the HAIC market for the major region

  • Major regions studied in the report include North America, Europe, Asia-Pacific, and Rest of the world

  • Company profiles of the HAIC market and the growth strategies adopted by the market players to sustain in the fast-growing market

  • Deep dive regional level analysis of the industry



Related Reports

Customers who bought this item also bought

Private Health Insurance Market: Current Analysis and Forecast (2024-2032)

Private Health Insurance Market: Current Analysis and Forecast (2024-2032)

Emphasis on Age Group (Senior Citizens, Adults, and Minors); Distribution channel (Direct Sales, Brokers/Agents, Banks, and Others); and Region/Country

June 20, 2024

India Catheter Market: Current Analysis and Forecast (2024-2032)

India Catheter Market: Current Analysis and Forecast (2024-2032)

Emphasis on Product Type (Cardiovascular Catheters, Urology Catheters, Intravenous Catheters, Neurovascular Catheters, and Specialty Catheters); Material Type (Silicone, Polyurethane, Latex, and Others); Region

November 4, 2024

Blood Pressure Cuffs Market: Current Analysis and Forecast (2024-2032)

Blood Pressure Cuffs Market: Current Analysis and Forecast (2024-2032)

Emphasis on Product Type (Manual, Automated), Usage Type (Reusable, Disposable), End-user (Hospitals, Home and Others); and Region/Country

October 16, 2024

Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)

Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)

Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country

October 8, 2024